EUVIMEDEUVIMED entdecken
Crossref

Endovascular Treatment of Femoropopliteal Tosaka III In Stent Re-stenosis

Xu Li, Yong Ding, Min Zhou, Ziheng Wu, Zibo Feng, Lianrui Guo, Qiang Li, Xin Fang, Meng Ye, Zhenyu Shi

European Journal of Vascular and Endovascular Surgery · 2026-03

DOI: 10.1016/j.ejvs.2026.03.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2026-03. Verfasst von Xu Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Zhongshan Hospital, Institute of Vascular Surgery, Fudan University, National Clinical Research Centre for Interventi…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Femoropopliteal in stent re-stenosis (ISR) remains a significant challenge following peripheral obstructive arterial disease endovascular procedures, with Tosaka III lesions representing the most complex form of complete occlusive re-stenosis. Limited prospective, observational study data have focused on endovascular treatment of femoropopliteal Tosaka III ISR. METHODS The FP-RESTORE study was a prospective, observational study involving 13 Chinese hospitals from April 2021. It enrolled 322 consecutive patients (353 limbs) with femoropopliteal Tosaka III ISR undergoing endovascular intervention. Primary endpoints were clinically driven target lesion revascularisation (CD-TLR) and major adverse limb events (MALE) at 24 months. Competing risk regression analysis was performed to identify independent predictors of adverse outcomes. RESULTS Of the enrolled patients, the mean age was 71.6 ± 9.1 years, with 54.67% presenting Rutherford grade > 3. Average occlusive lesion length was 22.0 ± 10.5 cm, with suspected thrombotic components presenting in 46.74% of lesions. Technical success rates were 96.88%. Ankle-brachial index (ABI) statistically significantly improved from 0.33 ± 0.2 to 0.77 ± 0.22 post-operatively; ABI improved by more than 0.2 after the procedure were observed in 85.8% of patients. The follow up rate was 86.0% with a median follow up duration of 24.5 months. At 24 months, the CD-TLR rate was 21.4% (95% confidence interval [CI] 16.82 - 25.93%) and MALE rate was 27.2% (95% CI 22.26 - 32.21%). All cause mortality was 14.3%. Independent predictors of CD-TLR and MALE included multiple previous procedures and popliteal artery (P2 and P3) involvement. CONCLUSION Endovascular treatment for femoropopliteal Tosaka III ISR could achieve acceptable immediate and 24 month outcomes. Multiple previous procedures and popliteal artery involvement were key predictors of adverse events, suggesting valuable guidance for risk stratification and treatment modification in this challenging patient population.

Schlagwörter

Stichwörter der Autor:innen

Drug coated balloonEndovascular treatmentFemoropopliteal arteryIn stent re-stenosisProspective observational study

Autor:innen und Institutionen

  • Department of Vascular Surgery, Zhongshan Hospital, Institute of Vascular Surgery, Fudan University, National Clinical Research Centre for Interventional Medicine, Shanghai, China.
  • Department of Vascular Surgery, the First Affiliated hospital of Medicine College of Zhejiang University, Hangzhou, China.
  • Department of Vascular Surgery, Liyuan Hospital Affiliated to Tongji Medical College of Huazhong University of Science &Technology, Wuhan, China.
  • Department of Vascular Surgery, Xuanwu Hospital Capital Medical University, Beijing, China.
  • Department of Vascular Surgery, Qingdao Haici hospital affiliated to Qingdao University, Qingdao, China.
  • Department of Vascular Surgery, Hangzhou First People's hospital of Medical College of Zhejiang University, Hangzhou, China.

Zitieren

APA

Li, X., Ding, Y., Zhou, M., Wu, Z., Feng, Z., Guo, L., Li, Q., Fang, X., Ye, M., & Shi, Z. (2026). Endovascular Treatment of Femoropopliteal Tosaka III In Stent Re-stenosis. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2026.03.012

Vancouver

Li X, Ding Y, Zhou M, Wu Z, Feng Z, Guo L, et al. Endovascular Treatment of Femoropopliteal Tosaka III In Stent Re-stenosis. European Journal of Vascular and Endovascular Surgery. 2026. doi:10.1016/j.ejvs.2026.03.012

BibTeX
@article{Li2026,
  author = {Li, Xu and Ding, Yong and Zhou, Min and Wu, Ziheng and Feng, Zibo and Guo, Lianrui and Li, Qiang and Fang, Xin and Ye, Meng and Shi, Zhenyu},
  title = {Endovascular Treatment of Femoropopliteal Tosaka III In Stent Re-stenosis},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2026},
  doi = {10.1016/j.ejvs.2026.03.012}
}
Kostenlos starten →